Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Genetic diversity of community-associated methicillin-resistant Staphylococcus aureus in southern Stockholm, 2000-2005.

Fang H, Hedin G, Li G, Nord CE.

Clin Microbiol Infect. 2008 Apr;14(4):370-6. doi: 10.1111/j.1469-0691.2007.01941.x. Epub 2008 Jan 11.

2.

The evolution of Staphylococcus aureus.

Deurenberg RH, Stobberingh EE.

Infect Genet Evol. 2008 Dec;8(6):747-63. doi: 10.1016/j.meegid.2008.07.007. Epub 2008 Jul 29. Review.

PMID:
18718557
3.

Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin.

Boyle-Vavra S, Daum RS.

Lab Invest. 2007 Jan;87(1):3-9. Epub 2006 Dec 4. Review.

4.

The molecular evolution of methicillin-resistant Staphylococcus aureus.

Deurenberg RH, Vink C, Kalenic S, Friedrich AW, Bruggeman CA, Stobberingh EE.

Clin Microbiol Infect. 2007 Mar;13(3):222-35. Review.

5.

Community-associated methicillin-resistant Staphylococcus aureus (MRSA) in Australia.

Nimmo GR, Coombs GW.

Int J Antimicrob Agents. 2008 May;31(5):401-10. doi: 10.1016/j.ijantimicag.2007.08.011. Epub 2008 Mar 14. Review.

PMID:
18342492
6.

Virulence determinants in community and hospital meticillin-resistant Staphylococcus aureus.

Tristan A, Ferry T, Durand G, Dauwalder O, Bes M, Lina G, Vandenesch F, Etienne J.

J Hosp Infect. 2007 Jun;65 Suppl 2:105-9. Review.

PMID:
17540252
7.

The molecular evolution of hospital- and community-associated methicillin-resistant Staphylococcus aureus.

Deurenberg RH, Stobberingh EE.

Curr Mol Med. 2009 Mar;9(2):100-15. Review.

PMID:
19275621
8.

Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives.

Kluytmans-Vandenbergh MF, Kluytmans JA.

Clin Microbiol Infect. 2006 Mar;12 Suppl 1:9-15. Review.

9.

A decade of community MRSA in New Zealand.

Smith JM, Cook GM.

Epidemiol Infect. 2005 Oct;133(5):899-904. Review.

10.

Community-associated methicillin-resistant Staphylococcus aureus: overview and local situation.

Wijaya L, Hsu LY, Kurup A.

Ann Acad Med Singapore. 2006 Jul;35(7):479-86. Review.

11.

Proposed definitions of community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA).

Millar BC, Loughrey A, Elborn JS, Moore JE.

J Hosp Infect. 2007 Oct;67(2):109-13. Epub 2007 Jul 31. Review.

PMID:
17669546
12.
13.

Impact of community-acquired methicillin-resistant Staphylococcus aureus in the hospital setting.

File TM Jr.

Cleve Clin J Med. 2007 Aug;74 Suppl 4:S6-11. Review.

PMID:
17847173
14.

Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus.

Oliveira DC, Tomasz A, de Lencastre H.

Lancet Infect Dis. 2002 Mar;2(3):180-9. Review. Erratum in: Lancet Infect Dis 2002 May;2(5):315.

PMID:
11944188
15.

[Community-associated methicillin-resistant Staphylococcus aureus: current status and molecular epidemiological perspective].

Ito T, Kuwahara K, Hisata K, Okuma K, Cui L, Hiramatsu K.

Kansenshogaku Zasshi. 2004 Jun;78(6):459-69. Review. Japanese.

PMID:
15287472
16.

Evolution and pathogenesis of Staphylococcus aureus: lessons learned from genotyping and comparative genomics.

Feng Y, Chen CJ, Su LH, Hu S, Yu J, Chiu CH.

FEMS Microbiol Rev. 2008 Jan;32(1):23-37. Epub 2007 Nov 5. Review.

Supplemental Content

Support Center